Cyanides: Chemical Warfare Agents and Potential Terrorist Threats

Chemical Warfare Agents: Toxicology and Treatment, Second Edition

Volumn , Issue , 2007, Pages 495-542

  Ballantyne, Bryan ^a   Bismuth, Chantal ^b   Hall, Alan H ^c  

^a Hôpital Fernand Widal ^*  (United States)

^b HÔPITAL FERNAND WIDAL   (France)

^c Toxicology Consulting and Medical Translating Services Inc (TCMS Inc)   (United States)

Author keywords

Cyanides and potential terrorist threats; Human lethal inhalation toxicity; Specific end point toxicologial assessments; Specific organ and tissue toxicity; Supportive medical management

Indexed keywords

EID: 68949210390     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470060032.ch25     Document Type: Chapter

References (354)

1. Acker H and Eyzaguirre C (1989). Light absorbance changes in the mouse carotid body during hypoxia and cyanide poisoning. Brain Res, 409, 380-385.
2. Aharony D, Smith JD and Smith MJ (1982). Inhibition of human platelet lipoxygenase by cyanide. Experientia, 38, 1334-1335.
3. Aitken PG and Braitman J (1989). The effect of cyanide on neuronal and synaptic function in hippocampal slices. Neurotoxicology, 10, 239-248.
4. Alvarez-Buylla R and Alvarez-Buylla ER de (1988). Carotid sinus receptors participate in glucose homeostasis. Resp Physiol, 72, 47-60.
5. Alvarez-Buylla R and Alvarez-Buylla ER de (1994). Changes in blood glucose concentration in the carotid-body sinus modify brain glucose retention. Brain Res, 654, 167-170.
6. Alvarez-Buylla R, Alvarez-Buylla E, Mendoza H et al. (1997). Pituitary and adrenals are required for hyperglycemic reflex initiated by stimulation of CBR with cyanide. Am J Physiol, 272, R392-R399.
7. American Cyanamid (1959). Report on sodium cyanide: 30-day repeated feeding study to dogs. Cyanamid Report Number 59-14. Princeton, NJ, USA: Central Medical Department, American Cyanamid.
8. Anderson AH (1946). Experimental studies on the pharmacology of activated charcoal. Acta Pharmacol, 2, 69-78.
9. Andrews JM, Sweeney ES, Grey TC et al. (1989). The biohazard potential of cyanide poisoning during postmortem examination. J Forens Sci, 34, 1280-1284.
10. Antonini EA, Brunoori M, Greenwood C et al. (1971). The interaction of cyanide with cytochrome oxidase. Eur J Biochem, 23, 396-400.
11. Ardelt KK, Borowitz JL, Maduh EU et al. (1994). Cyanide-induce lipid peroxidation in different organs: subcellular distribution and hydroperoxide generation in neuronal cells. Toxicology, 89, 127-137.
12. ATSDR (1997). Toxicological profile for cyanide. Agency for Toxic Substances and Disease Registry, US Public Health Service. ATSDR Toxicological Profiles on CD-ROM (Version 3:1; 2000). Boca Raton, FL, USA: Chapman and Hall/CRC Press.
13. Autor AP and Fridovich I (1970). The interactions of acetoacetate decarboxylase with carbonyl compounds, hydrogen cyanide, and an organic mercurial. J Biol Chem, 245, 5214-5222.
14. Baftis H, Smolens MH, His BP et al. (1981). Chronotoxicity of male BALB/cCr mice to potassium cyanide. In: Proceedings of International Symposium on Chronopharmacology and Chronotherapy, cited in Ballantyne (1987b).
15. Baker D (2004). Civilian exposure to toxic agents: emergency medical reponse. Prehosp Disaster Med, 19, 174-178.
16. Ballantyne B (1973). An experimental assessment of decreases in measurable cyanide levels in biological fluids. J Forens Sci Soc, 13, 111-117.
17. Ballantyne B (1974)). The forensic diagnosis of acute cyanide poisoning. In: Forensic Toxicology (B Ballantyne, ed.), pp. 99-113. Bristol, UK: Wright.
18. Ballantyne B (1975). Blood, brain and cerebrospinal fluid cyanide concentrations in experimental acute cyanide poisoning. J Forens Sci Soc, 15, 51-56.
19. Ballantyne B (1976). Changes in blood cyanide as a function of storage time and temperature. J Forens Sci Soc, 16, 305-310.
20. Ballantyne B (1977). An experimental assessment of the diagnostic potential of histochemical and biochemical methods for cytochrome oxidase in acute cyanide poisoning. Cell Molec Biol, 22, 109-123.
21. Ballantyne B (1979). Letter to the Editor. Clin Toxicol, 14, 311-312.
22. Ballantyne B (1983a). Acute systemic toxicity of cyanides by topical application to the eye. Cut Ocul Toxicol, 2, 119-129.
23. Ballantyne B (1983)b). The influence of exposure route and species on the acute lethal toxicity and tissue concentrations of cyanide. In: Developments in the Science and Practice of Toxicology (AWHayes,RC Schnell and TS Miya, eds), pp. 583-586. Amsterdam, The Netherlands: Elsevier Science Publishers.
24. Ballantyne B(1983c). Artifacts in the definition of toxicity by cyanide and cyanogens. Fund Appl Toxicol, 3, 40-408.
25. Ballantyne B (1984)). Comparative acute toxicity of hydrogen cyanide and its salts. In: Proceedings of the Fourth Annual Chemical Defense Bioscience Review. (RE Linstrom, ed.), pp. 477-501. Bethesda, MD, USA: US Army Medical Research Institute of Chemical Defense.
26. Ballantyne B (1986). Hazard evaluation of cyanide fumigant powder formulations. Vet Human Toxicol, 28, 42.
27. Ballantyne B (1987)a). Hydrogen cyanide as a product of combustion and a factor in morbidity and mortality from fires. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 248-291. Bristol, UK: Wright.
28. Ballantyne B (1987)b). Toxicology of cyanides. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 41-126. Bristol, UK: Wright.
29. Ballantyne B (1987)c). Post-mortem features and criteria for the diagnosis of acute lethal cyanide poisoning. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 217-247. Bristol, UK: Wright.
30. Ballantyne B (1988). Toxicology and hazard evaluation of cyanide fumigation powders. Clin Toxicol, 26, 325-335.
31. Ballantyne B (1994a). Acute percutaneous systemic toxicity of cyanides. Cut Ocul Toxicol, 13, 249-262.
32. Ballantyne B (1994b). Acute inhalation toxicity of hydrogen cyanide vapor to the rat and rabbit. Toxic Subst J, 13, 249-282.
33. Ballantyne B and Bright JE (1979a). Comparison of kinetic and end-point microdensitometry for the direct quantitative histochemical assessment of cytochrome oxidase activity. Histochem J, 11, 173-186.
34. Ballantyne B and Bright JE (1979b). A kinetic histochemical method for the determination of cytochrome oxidase activity. J Physiol London, 300, 1-2.
35. Ballantyne B and Salem H (2005)). Experimental, clinical, occupational toxicology and forensic aspects of hydrogen cyanide with particular reference to vapor exposure. In: Inhalation Toxicology, Second Edition (H Salem and A Katz, eds), pp. 709-794. Boca Raton, FL, USA: CRC Press.
36. Ballantyne B, Bright J, Swanston DW et al. (1972). Toxicity and distribution of free cyanides given intramuscularly. Med Sci Law, 12, 209-219.
37. Banerjee KK, Bishayee R and Marimutha P (1997). Evaluation of cyanide exposure and its effect on thyroid function of workers in a cable industry. J Occup Environ Med, 39, 258-260.
38. Barr S (1966). The microdetermination of cyanide. Its application to the analysis of whole blood. Analyst, 91, 268-272.
39. Baskin SI, Wilkerson G, Alexander K et al. (1987)). Cardiac effects of cyanide. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 138-155. Bristol, UK: Wright.
40. Bastian G and Mercker H (1959). Zur Frage der Zweckmäβigkeit der Inhalation von Amynitrit in der Behandlung der Cyanidvergiftung Nauny-Schmiedebergs. Arch Exp Pathol Pharmakol, 237, 285-295.
41. Baud FJ, Barriot P and Toffis V(1991). Elevated blood cyanide concentrations in victims of smoke inhalation. New England J Med, 325, 1761-1766.
42. BBC (2002). Cyanide plotters face terror charges. British Broadcasting Corporation, 21 February 2002 (http://news.bbc.uk/1/hi/world/europe/1833646.stm).
43. Beasley DMG and Glass WI (1998). Cyanide poisoning: pathophysiology and treatment recommendations. Occup Med, 48, 427-431.
44. Beasley RWR,Blow RJ, Lunau FW et al. (1978).Amyl nitrite and all that. J Soc Occup Med, 28, 142-143.
45. Bhattacharya R, Kumar P and Sachan AS (1994). Cyanide induced changes in dynamic pulmonary mechanics in rats. Ind J Physiol Pharmacol, 38, 281-284.
46. Bianco PJMB and Garcia RA (2004). First case of illegal euthanasia in Spain: oral potassium cyanide poisoning. Soud Lék, 49, 30-33.
47. Blanc P, Hogan M, Mallin K et al. (1985). Cyanide intoxication among silver reclaimingworkers.JAm Med Assoc, 253, 367-371.
48. Bondy SC and Komulainen H(1988). Intracellular calcium as an index of neurotoxic damage. Toxicology, 49, 35-41.
49. Bonsall JJ (1984). Survival without sequelae following exposure to 500 mgm-3 hydrogen cyanide. Human Toxicol, 3, 57-60.
50. Borders CL Jr and Fredivich I (1985). A comparison of the effects of cyanide, hydrogen peroxide, and phenylglyoxal on eukaryotic and prokaryotic Cu, Zn superoxide dismutases. Arch Biochem Biophys, 241, 472-476.
51. Borgohain R, Singh AK, Radhakrishna H et al. (1955). Delayed onset generalized dystonia after cyanide poisoning. Clin Neurol Neurosurg, 97, 213-215.
52. Borowitz JL, Kanthasamy A and Isom GE (1994). Toxicodynamics of cyanide. In: Chemical Warfare Agents (SM Somani, ed.), pp. 209-236. San Diego, CA, USA: Academic Press.
53. Borron S (2006). Blood cyanide and plasma cyanocobalamin concentrations after treatment of acute cyanide poisoning with hydroxocobalamin or vehicle in a canine model. Clin Toxicol, 44, 630.
54. Borron SW and Baud FJ (1996). Acute cyanide poisoning: clinical spectrum, diagnosis and treatment. Arh Hig Toksikol, 47, 307-322.
55. Boswell GW, Brooks DE, Murray AJ et al. (1988). Exogenous methemoglobin as a cyanide antidote in rats. Pharmaceut Res, 5, 749-752.
56. Boxer GE and Rickards JC (1951). Chemical determination of vitamin B12. IV. Assay of vitamin B12 in multivitamin preparations and biological materials. Arch Biochem, 30, 392-401.
57. Boxer GE and Rickards JC (1952). Studies on the metablism of the carbon of cyanide and thiocyanate. Arch Biochem, 39, 7-26.
58. Brahams D (1991). 'Sudafed capsules' poisoned with cyanide. Lancet, 337, 968.
59. Brierley JB, Brown AW and Calverley J (1976). Cyanide intoxication in the rat physiological and neuropathological aspects. J Neurol Neurosurg Psychiat, 39, 129-140.
60. Brierley JB, Prior PF, Calverley J et al. (1977). Cyanide intoxication in Macaca mullata. Physiological and neuropathological aspects. J Neurol Sci, 31, 133-157.
61. Bright JE and Marrs TC (1987). Effect of paminopropiophenone (PAPP), a cyanide antidote, on cyanide given by intravenous infusion. Human Toxicol, 6, 133-138.
62. Brink NG, Kuehl FA and Folkers K (1950). Vitamin B12: The identification of vitamin B12 as a cyanocobalt coordination complex. Science, 112, 354.
63. Brivet F, Delfraissy JF, Duche M et al. (1983). Acute cyanide poisoning recovery with non-specific supportive therapy. Intensive Care Med, 9, 33-35.
64. Brown KS and Robinette RR (1967). No simple pattern of inheritance in the ability to smell solutions of cyanide. Nature, 215, 406-408.
65. Bryson DD (1978). Cyanide poisoning. Lancet, i, 92.
66. Burrows GE and Way JL (1977). Cyanide intoxication in sheep: therapeutic value of oxygen or cobalt. Am J Vet Res, 38, 223-227.
67. Busquets S, Alvarez B, Van Royen M et al. (2001). Increased uncoupling protein-2 gene expression in brain of lipopolysaccharide-injected mice: Role of tumor necrosis factor-α? Biochim Biophys Acta, 1499, 249-256.
68. Camerino PW and King TE (1966). Studies on cytochrome oxidase. 3. Reaction of cyanide with cytochrome oxidase insoluble and particulate forms. J Biol Chem, 241, 970-979.
69. Camu F (1969). Effect of imidazole and cyanide upon rat tissue lipolysis. Arch Int Physiol Biochem, 77, 663-666.
70. Carella F, Grassi MP and Savoiard M (1988). Dystonic-parkinsonian syndrome after cyanide poisoning: clinical and MRI findings. J Neurol Neurosurg Psychiat, 51, 1345-1348.
71. Carroll JL, Gonzal D, Rector DM et al. (1996). Ventral medullary neuronal responses to peripheral chemoreceptor stimulation. Neuroscience, 73, 989-998.
72. CasselG(1995). Estimation of the convulsive effect of cyanide in rats. Pharmacol Toxicol, 77, 259-263.
73. Cassel G and Persson SA (1985). Effect of acute cyanide intoxication on central catecholaminergic pathways. Clin Toxicol, 23, 461-462.
74. Cassel G and Persson SA (1992). Effect of acute lethal cyanide intoxication on central dopaminergic pathways. Pharmacol Toxicol, 70, 148-151.
75. Cassel G, Karlsson L and Sellström ̊A (1991). On the inhibition of glutamic acid decarboxylase and gamma-amino butyric acid transaminase by sodium cyanide. Pharmacol Toxicol, 69, 238-241.
76. Centers for Disease Control (1991). Cyanide poisonings associated with over-the-counter medication-Washington State, 1991. J Am Med Assoc, 265, 1806-1807.
77. Centers for Disease Control (2005). Atypical reactions associated with heroin use-five states, January-April, 2005. Morbid Mortal Weekly Rep, 54, 793-796.
78. Chance B (1952). Spectra and related kinetics of respiratory pigments of homogenized and intact cells. Nature, 16, 215-221.
79. Chin RG and Calderon Y (2000). Acute cyanide poisoning: a case report. J Emerg Med, 18, 441-445.
80. Chung J and Wood JL (1971). Oxidation of thiocyanate to cyanide catalyzed by hemoglobin. J Biol Chem, 246, 555-560.
81. Cloud DS (2004). Long in US signs, a young terrorist builds grim resume. The Wall Street Journal (New York), February 10, p. 2.
82. CNN (2004). Cyanide arsenal stirs domestic terror fear. CNN News, January 30. (www.cnn.com/2004/US/southwest/01/30/cyanide.probe.ap/idex.html).
83. ComroeJM(1974). Physiology of Respiration, pp. 33-54. Chicago, IL, USA: Year Book Publishers.
84. Cottrell JE, Casthely P and Brodie JD (1978). Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin. New England J Med, 298, 809-811.
85. Coughlan MP, Johnson JL and Rajagopalan KV (1980). Mechanisms of inactivation of molybdoenzymes by cyanide. J Biol Chem, 255, 2694-2699.
86. Crampton RF, Gaun IF, Harris R et al. (1979). Effect of low cobalamin diet and chronic cyanide toxicity in baboons. Toxicology, 12, 221-234.
87. Craven N (2005). Assassin free to plot ricin error. Daily Mail (London), Thursday, April 14, pp. 6-7.
88. Curry AS (1963). Cyanide poisoning. Acta Pharmacol Toxicol, 20, 291-29.
89. Dahl AR (1989). The cyanide metabolizing enzyme rhodanese in rat nasal respiratory and olfactory mucosa. Toxicol Lett, 45, 199-203.
90. Dally S and Gaultier M (1976). Choc anaphylactique d̂uà l'hydroxocobalamine. Nouv Press Med, 5, 1917.
91. DalyMDeB and Scott MJ (1964). The cardiovascular effects of hypoxia in the dog with special reference to the contribution of the carotid body chemoreceptors. J Physiol London, 173, 201-204.
92. DeBush RF and Seidel LG (1969). Attempted suicide by cyanide. California Med, 10, 394-396.
93. DeFlora S (1981). Study of 106 organic and inorganic compounds in the Salmonella/microsome test. Carcinogenesis, 2, 283-298.
94. DesLauriers CA, Burda AM and Whal M (2006). Hydroxocobalamin as a cyanide antidote. Amer. J. Therap, 13, 161-165.
95. D'Mello GD (1987)). Neuropathological and behavioral sequelae of acute cyanide toxicosis in animal species. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 156-183. Bristol, UK: Wright.
96. Doherty PA, Ferm V and Smith RP (1982). Congenital malformations induced by infusion of sodium cyanide in Golden hamster, Toxicol Appl Pharmaceut, 64, 456-464.
97. DonnellyDF(1993). Response to cyanide of two types of glomoid cells in mature rat carotid body. Brain Res, 30, 157-168.
98. Drinker P (1932). Hydrocyanic gas poisoning by absorption through the skin. J Ind Hyg, 14, 1-2.
99. Dudley HC, Sweeney TR and Miller JW (1942). Toxicology of acrylonitrile (vinyl cyanide). II. Studies of effects of daily inhalation. J Ind Hyg Toxicol, 24, 255-258.
100. Dugard PH (1987). The absorption of cyanide through human skin in vitro from solutions of sodium cyanide and gaseous HCN. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 127-137. Bristol, UK: Wright.
101. Dunea G (1983). Death over the counter. Br Med J, 286, 211-212.
102. Edwards AC and Thomas ID (1978). Cyanide poisoning. Lancet, i, 92-93.
103. El Ghawabi SH, Gaffar MA, Esabarti AAet al. (1975). Chronic cyanide exposure: a clinical radioisotope and laboratory study. Br J Ind Med, 32, 215-219.
104. Ermans AM, Delange F and Van der Velden M(1972). Possible role of cyanide and thiocyanate in the etiology of endemic cretinism. Adv Exp Med Biol, 30, 455-486.
105. Espinoza OB, Perez M and Ramirez MS (1992). Bitter cassava poisoning in eight children: a case report. Vet Human Toxicol, 34, 65.
106. Estler CJ (1965). Metabolic alterations in the brain during the course of non-lethal potassium cyanide poisoning and the influence of cyanide antagonists. Naunyn-Schmeidebergs Arch Pharmacol, 51, 413-432.
107. FairleyA, Linton EC andWild FE (1934). The absorption of hydrocyanic vapor through skin. J Hyg, 34, 283-294.
108. Feldman JM and Feldman DD (1990). Sequelae of attempted suicide by cyanide ingestion: a case report. Int J Psychiat Med, 20, 173-179.
109. Fenney J and Brugen ASV (1973). Cyanide binding to carbonic anhydrase. Eur J Biochem, 34, 107-111.
110. Fernando GCA and Busuttil A (1991). Cyanide ingestion-case studies of four suicides. Am J Forens Med Pathol, 12, 241-24.
111. Finelli PF (1981). Changes in the basal ganglia following cyanide poisoning. J Comput Assist Tomog, 5, 755-756.
112. Fitzgerald LR (1954). Effect of injected sodium cyanide on newborn and adult mice Am J Physiol, 17, 60-62.
113. Fligner CL, Luthi R, Linkaiyte-Weiss E et al. (1987). Cyanide poisoning from capsule tampering: clinical, pathologic and toxicological aspects. In: Proceedings of the 39th Annual Meeting of the American Academy of Forensic Sciences, pp. 106-107, San Diego, CA.
114. Forsyth JG, Mueller PD and Becker CE (1993). Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. Clin Toxicol, 31, 277-294.
115. Fortin J-L, Giocant J-P, Ruttimann et al. (2006). Prehospital administration of hydroxocobalamin for smoke inhalation associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin. Toxicol, 44(Suppl 1), 37-44.
116. Frankenberg L and Sörbo B (1975). Effect of cyanide antidotes on the metabolic conversion of cyanide to thiocyanate. Arch Toxicol, 3, 81-89.
117. Fukayama H, Nasu M and Murakami S (1992). Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol, 127, 520-525.
118. FukumotoY, Nasu M and Murakami S (1957).Astudy on the sense of smell with respect to potassium cyanide solution and its hereditary transmission. Jpn J Human Genet, 2, 7-16.
119. Funata N, Song SY, Funata M et al. (1984). A study of experimental cyanide encephalopathy in the acute phase-physiological and neuropathological correlation. Acta Neuropathol, 64, 99-107.
120. Ganote GE, Worstell J and Kaltenlach JP (1976). Oxygen-induced enzyme release after irreversible myocardial injury. Am J Pathol, 84, 2735.
121. Garberg P, Äkerblom, E-L and Bolcsfoldi G (1988). Evaluation of a genotoxicity test measuring DNAstrand breaks in mouse lymphoma cells by alkaline unwinding and hydroxyapatite elution. Mut Res, 203, 155-176.
122. Gee DJ (1987). Cyanides in murder, suicide and accident. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 209-216. Bristol, UK: Wright.
123. Geller RJ, Elkins BR and Iknoian RC (1991). Cyanide toxicity from acetonitrile-containing false nail remover. Am J Emerg Med, 9, 268-270.
124. Goldstein F and Rieders F (1951). Formation of cyanide in dog and man following administration of thiocyanate. Am J Physiol, 167, 47-50.
125. Goodhart GL (1994). Patient treated with antidote kit and hyperbaric oxygen survives cyanide poisoning. Southern Med J, 87, 814-816.
126. Gorman DF (1989). Problems and pitfalls in the use of hyperbaric oxygen for the treatment of poisoned patients. Med Toxicol Adverse Drug Exp, 4, 393-399.
127. Gracia R and Shepherd G (2004). Cyanide poisoning and its treatment. Pharmacotherapy, 24, 1358-1365.
128. Graham DL, Laman D, Theodore J et al. (1977). Acute cyanide poisoning complicated by lactic acidosis and pulmonary edema. Arch Int Med, 137, 1051-1055.
129. Grandas F, Artieda J and Obeso JA(1989). Clinical and CT scan findings in a case of cyanide intoxication. Mov Disorders, 4, 188-193.
130. Greve KW, Bianchini KJ, Doane BM et al. (2005). Psychological evaluation of the emotional effects of a community toxic exposure. J Occup Environ Med, 47, 5159.
131. Guatelli MA (1964)). The toxicology of cyanides. In: Methods ofForensic Sciences,Volume 3 (AS Curry, ed.), pp. 233-265. New York, NY, USA: Academic Press.
132. Gunaseker PG, Ramesh GT, Borowitz JL et al. (1999). Involvement of caspase-3-like activity in cyanideinduced neuronal aptosis. Toxicologist, 48, 87.
133. Hall AH and Rumack BH (1986). Clinical toxicology of cyanide. Ann Emerg Med, 15, 1067-1074.
134. Hall AH and Rumack BH (1987). Hydroxycobalamin/sodium thiosulfate as a cyanide antidote. J Emerg Med, 5, 115-121.
135. Hall AH and Rumack BH (1998)). Cyanide and related compounds. In: Clinical Management of Poisoning and Drug Overdose, Third Edition (LM Haddad, MW Shannon and JF Winchester, eds), pp. 899-905. Philadelphia, PA, USA: WB Saunders.
136. Hall AH, Linden CH and Kulig KW (1986). Cyanide poisoning from laetrile: role of nitrite therapy. Pediatrics, 78, 269-272.
137. Hall AH, Rumack BH and Schaffer MI (1987)). Clinical toxicology of cyanide. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 312-333. Bristol, UK: Wright.
138. Hansen BA and Dekker EE (1976). Inactivation of bovine liver 2-keto-4-hydroxyglutarate aldolase by cyanide in the presence of aldehydes. Biochemistry, 15, 2912-2917.
139. Hantson J and Duprez T (2006). The value of morphological neuroimaging after exposure to toxic substances. Toxicol. Rev, 25, 87-98.
140. Harris R and Paxman J (1982). A Higher Form of Killing, p. 199. London, UK: Chatto and Windus.
141. Hart GB, Strauss MB and Lennon PA (1985). Treatment of smoke inhalation by hyperbaric oxygen. J Emerg Med, 3, 211-215.
142. Hathaway GJ and Proctor NH (2004). Chemical Hazards of theWorkplace, Fourth Edition, pp. 346-347. Hoboken, NJ, USA: John Wiley & Sons, Inc.
143. Haxhiu MA, Erokwu B, Van Lunteren E et al. (1993). Central and spinal effects of sodium cyanide on respiratory activity. J Appl Physiol, 74, 574-579.
144. Haymaker W, Ginzler JM and Ferguson RL (1952). Residual neuropathological effects of cyanide poisoning. Milit Med, 111, 231-246.
145. Hébert CD (1993). NTP Technical Report on toxicity studies of sodium cyanide (CAS No. 143-33-9). Administered in drinking water to F334/N rats and B6C3F1 mice. NIH Publication 94-3386, November. Research Triangle Park, NC, USA: National Institutes of Health, National Toxicology Program.
146. Herbert V (1975)). Drugs effective in megaloblastic anemias. In: The Pharmacological Basis of Therapeutics, Fifth Edition (LS Goodman and A Gilman, eds), pp. 1332-1346. New York, NY, USA: McMillan.
147. Herrting G, Kraupp O, Schnetz H et al. (1960). Untersuchungenüber die Folgen einer chronischen Verabreichung akuttoxischer Dosen von Natriumcyanid an Hunden. Acta Pharmacol Toxicol, 17, 27-42.
148. Higgins EA, Floea V, Thomas AA et al. (1972). Acute toxicity of brief exposures to HF, HCl, NO2 and HCN with and without CO. Fire Technol, 2, 120-130.
149. Hilado CJ and Cummings HJ (1977). A review of available LC50 data. J Combust Toxicol, 4, 415-424.
150. Hilmann B, Bardham KD and Bain JTB. (1974). The use of dicobalt edetate (Kelocyanor) in cyanide poisoning. Postgrad Med J, 50, 171-174.
151. Himwich WA and Saunders JP (1948). Enzymic conversion of cyanide to thiocyanate. Am J Physiol, 153, 348-354.
152. Hirano A, Levine S and Zimmerman HM (1967). Experimental cyanide encephalopathy. Electron microscopic observations of early lesions of white matter. J Neuropathol Exper Neurol, 26, 200-213.
153. HMSO (1987). Medical Manual of Defence Against Chemical Agents. London, UK: Her Majesty's Stationary Office.
154. Hoidal CR, Hall AH and Robinson MD (1986). Hydrogen sulfide poisoning from toxic inhalations of roofing asphalt fumes. Ann Emerg Med, 15, 826-830.
155. Holland DJ (1983). Cyanide poisoning: an uncommon encounter.J Emerg Nurs, 9, 138-140.
156. Holland MA and Koslowski IM (1986). Clinical features and management of cyanide poisoning. Clin Pharm, 5, 737-741.
157. Homan ER (1987)). Reactions, processes and materials with potential for cyanide exposure. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 1-21. Bristol, UK: Wright.
158. Houeto P, Borron SW, Sandouk P et al. (1996). Pharmacokinetics of hydroxocobalamin in smoke inhalation victims. Clin Toxicol, 34, 397-404.
159. Howard JW and Hanzal RF (1955). Chronic toxicity for rats of food treated with hydrogen cyanide. J Agr Food Chem, 3, 325-329.
160. Hoyer S (1984). The effect of naftidroturyl on cyanide induced hypoxic damage to glucose and energy metabolism in brain cortex of rats. Arzneim-Forsch, 34, 412-416.
161. Hume AS, Mozingo JR, McIntyre B et al. (1995). Antidotal efficacy of alpha-ketoglutaric acid and sodium thiosulfate in cyanide poisoning. Clin Toxicol, 33, 721-724.
162. Huser HJ, Moor-Jankowski JK, Truog G et al. (1958). Clinical, genetic and coagulation-physiologic aspects of Hemophilia B in the bleeders of Tenna, with a contribution on the genetics of the coagulation factors. Acta Genet, 8, 209-234.
163. Isom GE, Li DHW and Way JL (1975). Effects of sublethal doses of cyanide on glucose catabolism. Biochem Pharmacol, 24, 81-85.
164. Johnson RP and Mellors JW (1988). Arteriolization of venous blood gases: a clue to the diagnosis of cyanide poisoning. J Emerg Med, 6, 401-404.
165. Johnson JD, Meisenheimer TL and Isom GE (1986). Cyanide-induced neurotoxicity: role of neuronal calcium. Toxicol Appl Pharmac, 4, 64-68.
166. Kahler RL, Goldblatt A and Braunmad E (1962). The effects of acte hypoxia on the systemic venous and arterial systems and on myocardial contractile force. J Clin Invest, 41, 1553-1563.
167. Kales SN, Drinlage D, Dickey J et al. (1997). Paranoid psychosis after exposure to cyanide. Arch Environ Health, 52, 245-246.
168. Kamalu, BP and Agharanya JC (1991). The effect of a nutritionally-balanced cassava (Manihot esculenta Crantz) diet on endocrine function using the dog as a model. 2. Thyroid. Br J Nutrit, 65, 373-379.
169. Kanthasamy AG, Borowitz JL and Isom GE (1991). Cyanide-induced increases in plasma catecholamines: relationship to acute toxicity. Neurotoxicology, 12, 777-784.
170. Kanthasamy AG, Borowitz JL, Pavlakovic G et al. (1994a). Dopaminergic neurotoxicity of cyanide: neurochemical, histological and behavioral characterization. Toxicol Appl Pharmacol, 126, 156-163.
171. Kanthasamy AG, Borowitz JL, Pavlakovic G et al. (1994b). Interaction of cyanide with a dopamine metabolite: formation of a cyanohydrin adduct and its implications for cyanide-induced neurotoxicity. Neurotoxicology, 15, 887-896.
172. Katsumata Y, Sato K, Oya M et al. (1980). Kinetic analysis of the shift of aerobic metabolism in rats during acute cyanide poisoning. Life Sci, 27, 1509-1512.
173. Khan A, Levitt A, SageMet al. (2000). Biological and chemical terrorism: strategic plan for preparedness and response. Morbid MortalWeekly Rep, 49, 1-14.
174. Kiese M (1974). Methemoglobinemia: A Comprehensive Treatise, p. 80, Cleveland, OH, USA: CRC Press.
175. Kirk RL and Stenhouse NS (1953). Ability to smell solutions of potassium cyanide. Nature, 171, 698.
176. Kirk MA, Gerace R and Kulig KW (1993). Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kit. Ann Emerg Med, 22, 1413-1418.
177. Kiuchi Y, Inagaki M, Izumi J et al. (1992). Effects of local cyanide perfusion on rat striatal extracellular dopamine and its metabolites as studied by in vivo brain microdialysis. Neurosci Lett, 147, 193-196.
178. Klimmek R, Fladerer M and Weger N (1979). Circulation, respiration and blood homeostasis of dogs during slow cyanide poisoning and after treatment with 4-dimethylaminophenol or cobalt compounds. Arch Toxicol, 3, 121-133.
179. Korner PL (1959). Circulatory adaptations in hypoxia. Physiol Rev, 39, 687-730.
180. Krasney JA (1967). Efficient components of the cardioaccelerator responses to oxygen lack and cyanide. Am J Physiol, 213, 1475-1479.
181. Krasney JA (1970). Effects of sino-aortic denervation on regional circulatory responses to cyanide. Am J Physiol, 218, 56-63.
182. Krasney JA (1971). Cardiovascular responses to cyanide in awake sino-aortic denervated dogs. Am J Physiol, 220, 1361-1366.
183. Krasney JA, Hogan PM, Lowe RF et al. (1966). Comparison of the effects of hypoxia and cyanide on cardiac rate in spinal dogs. Fed Proc, 25, 2.
184. Kremer ML (1970). Inhibition of catalase by cyanide. Israel J Chem, 8, 790-807.
185. Kulig WK and Ballantyne B (1993). Cyanide toxicity. Am Fam Phys, 48, 107-114.
186. Kumar P, Das M and Kumar A (1992). Health status of workers engaged in heat treatment (case hardening) plant and electroplating at cyanide bath. Ind J Environ Protect, 12, 179-183.
187. Kushi A, Matsumoto T and Youmans WB (1983). Mutagen from the gaseous phase of protein hydrolysate. Agr Biol Chem, 47, 1979-1982.
188. Lafferty MA and Garet RH (1974). Purification and properties of the neurospora crassa assimilatory nitrite reductase. J Biol Chem, 249, 7555-7557.
189. Lafin SM, Lucchesi M, FedakMet al. (1992). A need to revise the cyanide antidote package instructions. J Emerg Med, 10, 623.
190. Lambert RJ, Kindler BL and Dschaeffer DJ (1988). The efficacy of superactivated charcoal in treating rats exposed to a lethal oral dose of potassium cyanide. Ann Emerg Med, 17, 595-598.
191. Lang K (1933). Rhodanbildung im Tierkörper. Biochem Z, 259, 243-256.
192. LaPostolle F, Borron S and Buad F (2006). Increased plasma lactate concentrations are associated with cyanide but not other types of acute poisoning. Clin. Toxicol, 44 (Suppl 1), 777.
193. Leading Article (2005). Poison plot. The Times (London), Thursday April 14, p. 19.
194. Lee-Jones M, Bennett MA and Sherwell JM (1970). Cyanide self-poisoning. Br Med J, 2, 780-781.
195. Leimdorfer A (1950). About anoxia of the heart roduced by intravenous sodium cyanide injections. Arch Int Pharmacodyn, 84, 181-18.
196. Lemberg MR (1969). Cytochrome oxidase. Physiol Rev, 49, 48-111.
197. Lendle L (1964).Wirkungsbedingngen und Blausäure und Schwefelwasserstoff und Möglichelten der Vergiftungsbehandlung. Jpn J Pharmacol, 14, 215-224.
198. Lessel S (1971). Experimental cyanide optic neuropathy. Arch Ophthalmol, 86, 194-204.
199. Leung P, Cannon EP, Petrkovics I et al. (1991). In vivo studies on rhodanese encapsulation in mouse carrier erythrocytes. Toxicol Appl Pharmacol, 110, 268-274.
200. Leuschner J, Winkler A and Leuscchner F (1991). In vivo studies on rhodanese encapsulation in mouse carrier erythrocytes. Toxicol Appl Pharmacol, 10, 268-274.
201. Levin BC, Gurman JL, Paabo M et al. (1987). Toxicological aspects of pure and mixed fire gases for various exposure times. Toxicologist, 7, 201.
202. Levine S (1975). Nonperipheral chemoreceptor stimulation of ventilation by cyanide. J. Appl. Physiol., 39, 199-204.
203. Levine S and Stypulkowski W (1959). Experimental cyanide encephalopathy. Arch Pathol, 6, 306-323.
204. Levine S and Wenk EJ (1959). Cyanide encephalopathy produced by intravenous route. J Nerv Mental Dis, 129, 302-305.
205. Li PP and White TD (1977). Rapid effects of veratridine, tetrodotoxin, garamicidin D, valinomycin, and NaCN on the Na+, K+ and ATP contents of synaptosomes. J Neurochem, 28, 967-975.
206. Li L, Prabhakaran K, Mills EM et al. (2005). Enhancement of cyanide-induced mitochondrial dysfunction and cortical cell necrosis by uncoupling protein-2. Toxicol Sci, 86, 116-124.
207. Linakis JG, Lacouture PG andWoolf A (1991). Monitoring cyanide and thiocyanate concentrations during infusion of sodium nitroprusside in children. Pediatr Cardiol, 12, 214-218.
208. Lindsay AE, Greenbaum AR and O'Hare D (2004). Analytical techniques for cyanide in blood and published blood cyanide concentrations from healthy subjects and fire victims. Anal Chim Acta, 51, 185-195.
209. Litovitz T (1987)). The use of oxygen in the treatment of acute cyanide poisoning. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 467-472. Bristol, UK: Wright.
210. Lovatt Evans C(1964). Cobalt compounds as antidotes for hydrocyanic acid. Br J Pharmacol, 23, 455-475.
211. Lundquist P, Roslig H and Sörbo B (1988). The origin of hydrogen cyanide in breath. Arch Toxicol, 61, 270-274.
212. Lundquist P, Kagedal B, Nilsson L et al. (1995). Analysis of the cyanide metabolite 2-aminothiazoline-4-carboxylic acid in urine by high performance liquid chromatography. Anal Biochem, 22, 1-8.
213. MacMillan VH (1989). Cerebral energy metabolism in cyanide encephalopathy. J Cerebral Blood Flow Metab, 9, 156-162.
214. Maduh EU, PorterDWand Baskin SI (1993). Calcium antagonists. A role in the management of cyanide poisoning. Drug Safety, 9, 237-248.
215. Maduh EU, Nealley EW, Song H et al. (1995). A protein kinase C inhibitor attenuates cyanide toxicity in vivo. Toxicology, 100, 129-137.
216. Marrs TC (1987)). The choice of cyanide antidotes. In: Clinical and Experimental Toxicology of Cyanides (B Ballantyne and TC Marrs, eds), pp. 383-401. Bristol, UK: Wright.
217. Marrs TC (1988). Antidotal treatment of acute cyanide poisoning. Adv Drug Reacti Acute Poison Rev, 4, 178-206.
218. Marsho TV and Kung SD (1976). Oxygenase properties of crystallized fraction I protein from tobacco. Arch Biochem Biophys, 173, 341-346.
219. Massey V and Edmondson D (1970). On the mechanism of inactivation of xanthine oxidase by cyanide. J Biol Chem, 45, 6595-6598.
220. Mathangi C and Namasivayam A (2000). Effect of chronic cyanide intoxication on memory in albino rats. Food Chem Toxicol, 38, 51-55.
221. Matijak-Schaper M and Alarie Y (1982). Toxicity of carbon monoxide hydrogen cyanide and low oxygen. J Combust Toxicol, 9, 21-61.
222. Maynard RL (1999)). Toxicology of chemical warfare agents. In: General and Applied Toxicology, Volume 3, Second Edition (B Ballantyne, TC Marrs and T Syversen, eds), pp. 2079-2109. London, UK: MacMillan.
223. McMillan DE and Svoboda AC (1982). The role of erythrocytes in cyanide detoxification. J Pharmacol Exp Therap, 21, 37-41.
224. McNamara BP (1976). Estimation of the toxicity of hydrocyanic acid vapors in man. Edgewood Arsenal Technical Report, Number EB-TR76023. Bethesda, MD, USA: US Department of the Army.
225. Mégarbane B and Baud F (2003). Cyanide poisoning: diagnosis and atidote choice in an emergency situation. Clin Toxicol, 41, 438-439.
226. Meredith TJ, Jacosen D, Haines JA et al. (1993). Antidotes for Cyanide Poisoning, Volume 2, International Program of Chemical Safety/Commission of the European Communities, Evaluation of Antidotes Series. Cambridge, UK: Cambridge University Press.
227. Messing B (1991). Extrapyramidal disturbances after cyanide poisoning (first MRI-investigation of the brain). J Neural Transm, 33, 141-147.
228. Meyer GW, Hart GB and Strauss MB (1991). Hyperbaric oxygen therapy for acute smoke inhalation injuries. Postgrad Med, 89, 221-223.
229. Mitra J, Dev NB, Trivedi R et al. (1993). Intramedullary sodium cyanide injection on respiratory and vasomotor responses in cats. Resp Physiol, 93, 71-82.
230. Moore S and Gates N (1946). Cited by McNamara (1976).
231. Moore SJ, Norris JC, Ing KH et al. (1986). The efficacy of alpha-ketoglutaric acid in the antagonism of cyanide intoxication. Toxicol Appl Pharmacol, 81, 265-273.
232. Nakatani T,KosugiY, MoriAet al. (1993). Changes in the metabolism of oxygen metabolism in a clinical course recovering from potassium cyanide. Am J Emerg Med, 11, 213-217.
233. NaughtonM(1974). Acute cyanide poisoning. Anesth Intensive Care, 4, 351-356.
234. Neiminen A-L, Gores GJ, Wray BE et al. (1988). Calcium dependence of bleb formation and cell death in hepatocytes. Cell Calcium, 9, 237-246.
235. Nicholls P, Van Burrn KJH and Van Gelder BF (1972). Biochemical and biophysical studies on the cytochrome aa3. Binding of cyanide to cytochrome aa3. Biochem Biophys Acta, 275, 279-287.
236. Nicholson PJ and Vincenti GEP (1994).Acase of phobic anxiety related to the inability to smell cyanide. Occup Med, 4, 107-108.
237. Nolte KB and Dasgupta A (1996). Prevention of occupational cyanide exposure in autopsy prosectors. J Forens Sci, 41, 146-148.
238. NTARC (2004). National terror alert: survival guide-facts about cyanide. National Terror Alert Resource Center (www.nationalterrorallert.com/readygude/cyanide.htm).
239. O'Flaherty EJ and ThomasWC(1982). The cardiotoxicity of hydrogen cyanide as a component of polymer hydrolysis smokes. Toxicol Appl Pharmac, 70, 335-339.
240. Okoh PN (1983). Excretion of 14C-labeled cyanide in rats exposed to chronic intake of potassium cyanide. Toxicol Appl Pharmac, 00, 00-00.
241. Okoh PN and Pitt GAJ (1982). The metabolism in the rat of cyanide and gastrointestinal circulation of the resulting thiocyanate under conditions of chronic cyanide intake. Can J Physiol Pharmacol, 60, 381-386.
242. Okolie NP and Osagie AU (1999). Liver and kidney lesions and associated enzyme changes induced in rabbits by chronic cyanide exposure. Food Chem Toxicol, 37, 745-750.
243. Okolie NP and Osagie AU (2000). Differential effects of chronic cyanide intoxication on heart, lung and pancreatic tissues. Food Chem Toxicol, 38, 543-548.
244. Okudera H, Morita H, Iwashita T et al. (1997). Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. Am J Emerg Med, 15, 527-528.
245. Olsen NS and Klein JR (1947). Effects of cyanide on the concentration of lactate and phosphates in brain. J Biol Chem, 167, 739-746.
246. O'Neill S (2005). Howhigh street poison plot ended in a bedsit bloodbath. The Times (London), Thusday April 14, pp. 6-7.
247. Owais W, Janakat S and Hunaiti A (1985). Activation of sodium cyanide to a toxic but nonmutagenic metabolite by Salmonella typhimurium. Mut Res, 144, 119-125.
248. Patel MN,Yim GKW. and Isom GE(1992). N-Methyl-D-aspartate receptors mediate cyanide-induced cytotoxicity in hippocampal cultures. Neurotoxicology, 14, 35-40.
249. Paulet G(1955). On the relative importance of respiratory failure and cardiac failure in the lethal action of cyanides. Arch Int Physiol Biochem, 63, 280-339.
250. Paulet G (1961). Nouvelles perspective dans le traitement de l'intoxication cyanhydrique. Arch Mal Prof, 22, 120-127.
251. Peddy SB, Rigby MR and Shaffner DH (2006). Acute cyanide poisoning. Pediatr Clin Care Med, 7, 79-82.
252. Peden NR, Taha R, McSorley PD et al. (1986). Industrial exposure to hydrogen cyanide: implications for treatment. Br Med J, 293, 538.
253. Persson S-̊ A, Cassel G and Sellström, Å (1985). Acute cyanide intoxication and central transmitter systems. Fund Appl Toxicol, 5, S150-S159.
254. Pettersen JC and Cohen SD (1985). Antagonism of cyanide poisoning by chlorpromazine and sodium thiosulfate. Toxicol Appl Pharmac, 81, 265-273.
255. Pettersen JC and Cohen SD (1986). Comparison of the effects of cyanide (CN) on cytochrome oxidase (cyt ox) activity and respiration in mouse brain mitochondria (mito). Toxicologist, 6, 199.
256. Pettersen JC and Cohen SD (1993). The effect of cyanide on brain mitochondrial cytochrome oxidase and respiratory activities. J Appl Toxicol, 13, 9-14.
257. Philbrick DJ, Hopkins JB, Hil DC et al. (1979). Effects of prolonged cyanide and thiocyanate feeding in rats. J Toxicol Environ Health, 5, 579-592.
258. Piantadosi CA and Silvia AL (1986). Cerebral cytochrome a, a3 inhibition by cyanide in bloodless rats. Toxicology, 33, 67-79.
259. Piantadosi CA, Sylvia DL and Jöbsis FF (1983). Cyanide-induced cytochrome a, a3 oxidationreduction responses in rat brain in vivo. J Clin Invest, 72, 1224-1233.
260. Pines KL and Crymble MM (1952). In vitro conversion of thiocyanate to cyanide in the presence of erythrocytes. Proc Soc Exp Biol Med, 81, 160-163.
261. Pitt BR, Radford EP, Gurtner GL et al. (1979). Interaction of carbon monoxide and cyanide on cerebral circulation and metabolism. Arch Environ Health, 34, 354-359.
262. Pontal PG, Bismuth C, Garnier R et al. (1982). Therapeutic attitudes in cyanide poisoning. Retrospective study of 34 non-lethal cases. Vet Human Toxicol, 24 (Supplement), 90-93.
263. Ponte J and Sadler CI (1989). Studies on the regenerated carotid sinus nerve of the rabbit. J Physiol London, 410, 411-424.
264. Porter DJT, Voet JG and Bright HT (1972). Reduction of d-amino oxidase by β-chloraniline: enhancement of the reduction rate by cyanide. Biochim Biophys Res Commun, 49, 257-263.
265. Poulton JE (1988). Localization and catabolism of cyanogenic glycosides. In: Cyanide Compounds in Biology, Ciba Foundation Symposium Number 40, pp. 67-91. Chichester, UK: John Wiley & Sons, Ltd.
266. Prabhakaran K, Li L, Borowitz JL et al. (2003). Cyanide induces different modes of death in cortical and mesencephalic cells. J Pharmacol Exper Therap, 303, 510-519.
267. Prentiss AM (1937). Chemicals in War. New York, NY, USA: McGraw-Hill.
268. Pronczuk de Garbino J and Bismuth C (1981). Propositions thérapeutiques actuelles en cas d'intoxification par les cyanures. Toxicol Eur Res, III (2), 690-756.
269. Purser DA, Grimshaw P and Berrill KP (1984). Intoxication by cyanide in fires: a study in monkeys using polyacrylonitrile. Arch Environ Health, 39, 394-400.
270. Radojicic B (1973). Determining thiocyanate in urine of workers exposed to cyanide. Arch Hig Rada Toksikol, 24, 227-232.
271. RAMC (2002). Cyanogen agents. J R Army Med Corps, 148, 383-386.
272. Reitveld EC, Delbressine LPC, Waegenmaekers THJM et al. (1983). 2-Chlorobenzylmercapturic acid, a metabolite of the riot control agent 2-chlorobenzylidene malononitrile (CS) in the rat. Arch Toxicol, 5, 139-144.
273. Rella J, Marcus S and Wagner BJ (2003). Rapid cyanide detection using the Cyantesmoreg; kit. Clin Toxicol, 41, 736.
274. Rella J, Marcus S and Wagner BJ (2004). Rapid cyanide detection using the Cyantesmoreg; kit. Clin Toxicol, 42, 897-900.
275. Rickwood D, Wilson MT and Darley-Usmar VM (1987)). Isolation and characteristics of intact mitochondria. In: Mitochondria: A Practical Approach (VM Darley-Usmar, D Rickwood and MTWilson, eds), pp. 1-16. Oxford, UK: IRL Press.
276. Robinson CP, Baskin SI and Franz DR (1984). The effects of cyanide on isolated aorta strips from the dog, rabbit and ferret. Toxicologist, 4, 103.
277. Robinson CP, Baskin SI, Visnich N Jr et al. (1985a). The effect of cyanide and its interactions with norepinephrine on isolated aorta strips from the rabbit, dog and ferret. Toxicology, 35, 59-72.
278. Robinson CP, Baskin SI and Franz DR (1985b). The mechanisms of action of cyanide on the rabbit aorta. J Appl Toxicol, 5, 372-377.
279. Rosenberg NL, Myers JA and Martin WRW (1989). Cyanide-induced parkinsonism: clinical, MRI and 6-fluorodopa/PET studies. Neurology, 39, 142-144.
280. Rotenberg JS (2003). Cyanide as a weapon of terror. Pediat Ann, 32, 236-240.
281. Rousset S, Alves-Guerrra M-C, Mozo J et al. (2004). The biology of mitochondrial uncoupling proteins. Diabetes, 15, S130-S135.
282. Russek M, Fernandez A and Vegas C (1963). Increase in cerebral blood flow produced by low dosages of cyanide. Am J Physiol, 204, 309.
283. Rutkowski JV, Roebuck RJ and Smith RP (1985). Effect of protein free diet and food deprivation on hepatic rhodanese activity, serum proteins and acute cyanide lethality in mice. J Nutrit, 115, 132-136.
284. Rutkowski JV, Roebuck RJ and Smith RP(1986). Liver damage does not increase the sensitivity of mice to cyanide given acutely. Toxicology, 38, 305-314.
285. Ruzo LO, Unai T and Casda IE (1978). J Agr Food Chem, 26, 916-925.
286. Saia B, DeRosa E and Penney DG (1970). Remarks on the chronic poisoning from cyanide. Med Lav, 61, 580-586.
287. Salkowski AA and Penney DG (1994). Cyanide poisoning in animals and humans: a review. Vet Human Toxicol, 36, 455-466.
288. Salkowski AA and Penney DG(1995). Metabolic, cardiovascular and neurologic aspects of acute cyanide poisoning in the rat. Toxicol Lett, 75, 1-27.
289. Sandberg CG(1967).Acase of chronic poisoning with potassium cyanide? Acta Med Scand, 181, 233-236.
290. Sauter SW and Keim ME (2001). Hydroxocobalamin: improved public health readiness for cyanide disaster. Ann Emerg Med, 37, 635-641.
291. Sayek I (1970). The incidence of the inability to smell solutions of potassium cyanide in the rural health center of Ortabereket. Turk J Pediatr, 12, 72-75.
292. Schulz V (1984). Clinical pharmacokinetics of nitroprusside, cyanide, thiosulfate and thiocyanate. Clin Pharmacokin, 9, 239-251.
293. Schulz V, Bonn R and Kindler J (1979). Kinetics of elimination of thiocyanate in 7 healthy subjects and 8 subjects with renal failure. Klin Wochenschr, 57, 243-247.
294. Schulz V, Loffler A and Gheorghiu T (1983). The absorption of hydrocyanic acid from Linseed. Leber Magen Dar, 13, 10-14.
295. Seagrave S (1982). Yellow Rain, p. 150. London, UK: Abacus.
296. Sheehy M and Way JL (1968). Effect of oxygen on cyanide intoxication: III. Mithridate. J Pharmacol Exp Therap, 161, 163-168.
297. Shou Y, Li L, Prabhakaran K et al. (2003). p45 Mitogen-activated protein kinase contributes to Bax translocation and cytochrome c release in cyanide-induced apoptosis. Toxicol Sci, 75, 99-107.
298. Silver EH, Kuttab SH, Hassan T et al. (1982). Structural considerations in the metabolism of nitriles to cyanide in vivo. Drug Metab Dispos, 10, 495.
299. Simon JD (1999)). The emerging threat of chemical and biological terrorism. In: General and Applied Toxicology, Volume 3, Second Edition (B Ballantyne TC Marrs and T Syversen, eds), pp. 1722-1730. London, UK: MacMillan.
300. Singh JD (1982). The lethality and teratogenicity of potassium cyanide in the rat. Teratology, 25, 84A.
301. Smith ADM, Duckett S and Waters AH (1963). Neuropathological changes in chronic cyanide intoxication. Nature, 200, 179-181.
302. Solomonson LP (1982)). Cyanide as a metabolic inhibitor. In: Cyanide in Biology (B Vennesland, EE Conn, CJ Knowles et al., eds), pp. 11-28. New York, NY, USA: Academic Press.
303. Sörbo B (1975)). Thiosulphate sulfurtransferase and mercaptopyruvate sulfurtransferase. In: Metabolic Pathways, Volume 7, Metabolism of Sulfur Compounds (DM Greenberg, ed.), pp. 433-456. New York, NY, USA: Academic Press.
304. Sotto-Blanco B, Sousa B, Manzano JL et al. (2001). Does prolonged cyanide exposure have a diabetogenic effect? Vet Human Toxicol, 43, 106-108.
305. Sousa AB, Soto-Blanco B, Guerra JL et al. (2002). Does prolonged oral exposure to cyanide promote hepatotoxicity and nephrotoxicity? Toxicology, 174, 87-95.
306. Steffens W (2003). Percutaneous hydrocyanic acid poisoning. Clin Toxicol, 41, 483.
307. Sternbach G (1992). Editor's comment. J Emerg Med, 10, 623-624.
308. Suskind R(2006). The One Percent Doctrine, pp. 194-198. New York, NY, USA: Simon and Shuster.
309. Susuki T (1968). Ultrastructural changes of heart muscle in cyanide poisoning. Tohoku J Exp Med, 95, 271-287.
310. Tanberger G (1970). The stimulating effect of cyanide on central nervous system, vagus and sympathetic activities and its importance on circulation. Arch Int Pharmacodyn, 187, 61-66.
311. Tendler S and O'Neill S (2005). The al-Qaeda plot to poison Britain. The Times (London), Thursday April 14, p 1.
312. Tewe OO and Maner JH (1981a). Long-term and carryover effect of dietary inorganic cyanide (KCN) in the life cycle performance of and metabolism of rats. Toxicol Appl Pharmac, 58, 1-7.
313. Tewe OO and Maner JH (1981b). Performance and pathophysiological changes in pregnant pigs fed cassava diets containing different levels of cyanide. Res Vet Sci, 30, 147-151.
314. Thompson JP (2004). The use of antidotes in the emergency treatment of cyanide poisoning. Clin Toxicol, 42, 411.
315. Thompson SJ and Bayer MJ (1983). Access to cyanide antidote kits. Ann Emerg Med, 12, 515-516.
316. Thompson RL, Manders WW and Cowan WR (1987). Postmortem findings of the victims of the Jonestown tragedy. J Forens Sci, 32, 433-443.
317. Tomaszewski CA and Thom SR (1994). Use of hyperbaric oxygen in toxicology. Emerg Med Clin N Am, 12, 437-459.
318. Tursky T and Sajter V (1962). The influence of potassium cyanide poisoningon the γ-aminobutyric acid level in rat brain. J Neurochem, 9, 519-523.
319. Tyrer FH (1981). Treatment of cyanide poisoning. J Soc Occup Med, 31, 65-66.
320. Uhl W, Nolting A, Golor G et al. (2006). Safety of hydroxocobalamin in healthy volunteers in a randomized placebo controlled study. Clin Toxicol, 44, 17-28.
321. Utti RJ, Rajput AH, Ashenhurst EM et al. (1985). Cyanide-induced parkinsonism: a clinicopathologic report. Neurology, 35, 921-925.
322. Van der Heyden G, Vereecka J and Carmliet E (1985). The effect of cyanide on the K-current in guinea pig ventricular myocytes. Basic Res Cardiol, 80 (Supplement 1), 3-96.
323. Van Buuren KJH, Nicholls P and Van Geler PF (1972). Biochemical and biophysical studies on cytochrome a,a3. VI. Reaction of cyanide with oxidized and reduced enzyme. Biochim Biophys Acta, 256, 257-276.
324. Varnell RM, Stimac GK and Fligner CL (1987). Ct diagnosis of toxic brain injury in cyanide poisoning: considerations for forensic medicine. Am J Neuroradiol, 8, 1063-1066.
325. Vennesland B, Castric PA, Conn PE et al. (1982). Cyanide metabolism. Fed Proc, 41, 263-264.
326. Verna A, Roumy M and Leitner LM (1975). Loss of chemoreceptive properties of the rabbit carotid body after destruction of the glomus cells. Brain Res, 100, 13-23.
327. Vesey CJ (1976). Letter to the Editor. Clin Toxicol, 14, 307-309.
328. Vesey CJ and Wilson J (1978). Red cell cyanide. J Pharmac Pharmacol, 30, 20-26.
329. Vesey CJ, Cole PV and Simpson PJ (1976). Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man. Br J Anaesthesiol, 48, 651-660.
330. Vick JA and Froelich HL (1985). Studies on cyanide poisoning. Arch Int Pharmacody, 273, 314-322.
331. Watts J (1998). Japanese fear over festival cyanide poisoning. Lancet, 352, 379.
332. Way JL (1984). Mechanism of cyanide intoxication and its antagonism. Ann Rev Pharmacol Toxicol, 24, 451-481.
333. Way JL and Burrows GE (1976). Cyanide intoxication: protection with chlorpromazine. Toxicol Appl Pharmacol, 36, 1-5.
334. Weger NP (1983). Treatment of cyanide poisoning with 4-dimethylaminophenol: experimental and clinical overview. Fund Appl Toxicol, 3, 387-396.
335. Westley J (1981)). Cyanide and sulfane sulfur. In: Cyanide in Biology (B Vennesland, EE Conn, CJ Knowles et al., eds), pp. 61-76. London, UK: Academic Press.
336. Westley J, Adler H, Westley I et al. (1983). The sulfurtransferases. Fund Appl Toxicol, 3, 377-382.
337. Wexler J, Whittenberger JL and Umke PR (1947). The effect of cyanide on the electrocardiogram of man. Am Heart J, 34, 163-173.
338. Wisler JA, Dulaney MD, Pellicore LS et al. (1991). Transport of cyanide into guinea pig cardiac mitochondria. Toxicol Lett, 56, 275-281.
339. Wood JL and Cooley SL (1956). Detoxification of cyanide by cystine. J Biol Chem, 21, 449-457.
340. Worksafe Australia (1989). Cyanide Poisoning, National Occupational Health and Safety Commission, Publication Number WAP 89/032. Canberra, Australia: Australian Government Publishing Service.
341. Wróbel M, Jurkowska H, Śliwa L et al. (2004). Sulfurtransferases and cyanide detoxification in mouse liver, kidney and brain. Toxicol Mech Methods, 14, 331-337.
342. Yamamoto H (1989). Hyperammonemia, increased brain neutral and aromatic amino acid levels, and encephalopathy induced by cyanide in mice. Toxicol Appl Pharmac, 9, 415-420.
343. Yamamoto H (1990). Protection against cyanideinduced convulsions with α-ketoglutarate. Toxicology, 61, 221-228.
344. Yamamoto H (1992). A possible mechanism for the increase in brain tyrosine levels induced by cyanide in mice. Food Chem Toxicol, 11, 973-977.
345. Yamamoto H (1993a). Protective effect of calmodulin inhibitors against acute cyanide-induced lethality and convulsions in mice. Toxicol Lett, 66, 73-79.
346. Yamamoto H (1993b). Relationship among cyanideinduced encephalopathy, blood ammonia levels and brain aromatic amino acid levels in rats. Bull Environ Contamin Toxicol, 50, 249-281.
347. Yamamoto H (1995). A hypothesis for cyanide induced and toxic seizures with supporting evidence. Toxicology, 5, 19-26.
348. Yamamoto H and Tang H-W (1996a). Effect of carbetapentane or melatonin on cyanide-induced neurotoxicity in mice. Jpn J Toxicol Environ Health, 6, 488-491.
349. YamamotoHand Tang H-W (1996b). Antagonistic effect of melatonin against cyanide-induced seizures and acute lethality in mice. Toxicol Lett, 7, 19-24.
350. Yamamoto H and Tang HW (1998). Effects of 2-amino-7-phosphonoheptanoic acid, melatonin or NG-nitro-l-arginine on cyanide or N-methyl-daspartate-induced neurotoxicity in rat cortical ells. Toxicol Lett, 94, 13-18.
351. Yamamoto K and Yamamoto Y (1977). The blood acid-base changes in acute cyanide poisoning in the rat in comparison with those in acute anoxic anoxia.With special references to the relation with time to death. Z Rechtsmed, 79, 125-135.
352. Yen D, Tsai ZJ and Wang M.-L (1995). The clinical experience of acute cyanide poisoning.AmJ Emerg Med, 13, 524-528.
353. Yonetani T and Ray GS(1965). Studies on cytochrome oxidase. VI. Kinetics of the aerobic oxidation of ferro-cytochrome by cytochrome oxidase. J Biol Chem, 24, 634-638.
354. Zanetti G, Galante YM, Arosio P et al. (1973). Interactions of succinate dehydrogenase with cyanide. Biochim Biophys Acta, 321, 41-53.